These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6361371)

  • 1. [Early detection of diabetic nephropathy: serum beta 2-microglobulin].
    Goebel FD; Schmeidl T; Füessl HS; Vogel S
    Klin Wochenschr; 1983 Dec; 61(23):1209-15. PubMed ID: 6361371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy.
    Aksun SA; Ozmen D; Ozmen B; Parildar Z; Mutaf I; Turgan N; Habif S; Kumanlioğluc K; Bayindir O
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):195-200. PubMed ID: 15127324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring progression of diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM
    Ups J Med Sci; 1985; 90(1):15-23. PubMed ID: 3890316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of serum creatinine and estimated glomerular filtration rate variability with diabetic retinopathy in Asians with type 2 diabetes: A nested case-control study.
    Zhang X; Kumari N; Low S; Ang K; Yeo D; Yeoh LY; Liu A; Kwan PY; Tang WE; Tavintharan S; Sum CF; Lim SC
    Diab Vasc Dis Res; 2018 Nov; 15(6):548-558. PubMed ID: 30014713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring glomerular function in diabetic nephropathy. A prospective study.
    Viberti GC; Bilous RW; Mackintosh D; Keen H
    Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in renal protein excretion and kidney function in type I diabetic patients during and following pregnancy in relation to the stage of preexistent diabetic nephropathy].
    Biesenbach G; Stöger W; Zazgornik J
    Klin Wochenschr; 1987 Nov; 65(21):1048-53. PubMed ID: 3431031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic hypouricemia as an indicator of clinical nephropathy.
    Shichiri M; Iwamoto H; Marumo F
    Am J Nephrol; 1990; 10(2):115-22. PubMed ID: 2190467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of diabetic nephropathy].
    Hasslacher C; Ritz E
    Dtsch Med Wochenschr; 1985 Oct; 110(43):1662-3. PubMed ID: 3899572
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta 2-microglobulinaemia: a sensitive index of diminishing renal function in diabetics.
    Viberti GC; Keen H; Mackintosh D
    Br Med J (Clin Res Ed); 1981 Jan; 282(6258):95-8. PubMed ID: 6161671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between beta 2 microglobulinemia and renal function in diabetes].
    Birch K; Hildebrandt P; Marshall MO; Sestoft L
    Ugeskr Laeger; 1984 Sep; 146(37):2773-5. PubMed ID: 6393497
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma and urine beta-thromboglobulin determination in the detection of thrombocyte hyperactivation in diabetic nephropathies].
    Tóth L; Szénási P; Varsányi-Nagy M; Szilvási I; Lehoczky E; Németh C; Kammerer L; Romics L
    Orv Hetil; 1991 May; 132(21):1135-8, 1141. PubMed ID: 1828563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
    Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate estimation of glomerular filtration rate in diabetic nephropathy from age, body weight, and serum creatinine.
    Sampson MJ; Drury PL
    Diabetes Care; 1992 May; 15(5):609-12. PubMed ID: 1516478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of serum beta 2-microglobulin in diabetes mellitus].
    Serban V; Deutsch G; Băcanu G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):171-5. PubMed ID: 2875505
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus.
    Hultberg B; Agardh E; Andersson A; Brattström L; Isaksson A; Israelsson B; Agardh CD
    Scand J Clin Lab Invest; 1991 May; 51(3):277-82. PubMed ID: 1882179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in serum retinol-binding protein 4 in the type 2 diabetic subjects with nephropathy.
    Murata M; Saito T; Otani T; Sasaki M; Ikoma A; Toyoshima H; Kawakami M; Ishikawa SE
    Endocr J; 2009; 56(2):287-94. PubMed ID: 19122345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.